|
| In-hospital mortality | |||
N | n | (%) | p-value | ||
All | 5039 | 53 | (1.1) |
| |
Sex | Male | 2913 | 34 | (1.2) |
|
Female | 2126 | 19 | (0.9) | 0.347 | |
Age (years) | ≤59 | 4032 | 41 | (1.0) |
|
60 - 69 | 763 | 6 | (0.8) |
| |
≥70 | 244 | 6 | (2.5) | 0.074 | |
Distant metastasis | No | 4102 | 33 | (0.8) |
|
Yes | 937 | 20 | (2.1) | <0.001 | |
G-CSF | No | 2279 | 10 | (0.4) |
|
Yes | 2760 | 43 | (1.6) | <0.001 | |
Diabetes mellitus | No | 4853 | 44 | (0.9) |
|
Yes | 186 | 9 | (4.8) | <0.001 | |
Surgery | No | 4670 | 50 | (1.1) |
|
Yes | 369 | 3 | (0.8) | 0.640 | |
Deep vein thrombosis | No | 4994 | 52 | (1.0) |
|
Yes | 45 | 1 | (2.2) | 0.439 | |
Blood transfusion (mL) | 0 | 3998 | 10 | (0.3) |
|
1 - 2499 | 728 | 11 | (1.5) |
| |
≥2500 | 313 | 32 | (10.2) | <0.001 | |
Chemotherapy | IFM + ADR | 1411 | 18 | (1.3) |
|
IFM | 884 | 8 | (0.9) |
| |
IFM + ETO | 753 | 4 | (0.5) |
| |
ADR | 545 | 4 | (0.7) |
| |
ADR + CDDP | 448 | 4 | (0.9) |
| |
CDDP | 200 | 2 | (1.0) |
| |
MTX | 198 | 1 | (0.5) |
| |
Others | 600 | 12 | (2.3) | 0.237 |